Focus
View

Royalty Pharma plc

RPRX · FY2025

MIXED

CEO Package

$938K

Pay Ratio

—

Pablo Legorreta

Awaiting a fuller pay-performance history

ELI LILLY & Co

LLY · FY2025

ALIGNED

CEO Package

$30.2M

Pay Ratio

—

David A. Ricks

Returns outran pay growth by +3.5 pts

JOHNSON & JOHNSON

JNJ · FY2025

ALIGNED

CEO Package

$32.8M

Pay Ratio

—

J. Duato

Returns outran pay growth by +16.0 pts

CEOTotal Compensation — All Companies

RPRX$938KLLY$30.2MJNJ$32.8M

All values are grant-date fair value as reported in proxy statements.

Key Differences

The fastest way to read this comparison before dropping into the tables.

JNJ carries the largest package at $32.8M, about 34.9x RPRX.
RPRX reads mixed, while LLY looks aligned.
LLY is the most equity-heavy package, while RPRX leans hardest on base salary.

Pay Component Breakdown

Latest CEO package mix by company. This stays on the CEO package even if the chart above is showing Top 5 pay.

RPRX

Pablo Legorreta

$938K

base salary100%

LLY

David A. Ricks

$30.2M

base salary6%
stock awards77%
other compensation2%

JNJ

J. Duato

$32.8M

base salary5%
stock awards46%
option awards18%
non-equity incentive compensation13%
other compensation2%

Quick Comparison

CompanyCEOLatest YearTotal Comp
Royalty Pharma plc(RPRX)Pablo Legorreta2025$0.9M
ELI LILLY & Co(LLY)David A. Ricks2025$30.2M
JOHNSON & JOHNSON(JNJ)N/A2025N/A

Note: All compensation values shown are grant-date fair value as reported in proxy statements. Direct comparisons should account for differences in company size, industry, and compensation structure.

Want to know when these numbers change?

We’ll email you when these companies file a new proxy — so you can see how CEO pay, equity awards, and ratios shift before the next headline.